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Abstract
The main aims of this paper are (a) to construct a generic conceptual model for the
Triple Helix model based on competence sets and hence (b) to identify the system-
level generic competencies needed in the emergence of a new industry. This paper
suggests that to gain additional analytical leverage on the Triple Helix model, we
need to study it also by focusing on generic competencies called for in the
interaction between the main institutional spheres. Hence, there is a need to focus
on interacting and conflicting system-level generic competencies that either
enhance or hamper innovation processes. It is believed here that a competence set
is the core of any Triple Helix constellation, but it is also believed that different
competencies are manifested in a variety of ways depending on the nature of the
specific system and related industries. The competence set model is elaborated upon
by using the emergence of human spare parts industry in Tampere, Finland, as an
illustrative case to highlight the otherwise conceptual discussion.
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Résumé
Les objectifs principaux de cet article sont : (a) de construire un modèle conceptuel
générique de Triple Hélice basé sur le jeu des compétences et ainsi (b) d’identifier les
compétences génériques au niveau système nécessaires à l’émergence d’une nouvelle
entreprise. Cet article suggère que pour obtenir un effet de levier analytique
supplémentaire sur le modèle de la Triple Hélice, il importe de l’étudier également en
mettant l’accent sur les compétences génériques nécessaires à l’interaction entre les
principales sphères institutionnelles. Par conséquent, il est nécessaire de s’appesantir sur
les compétences génériques d’interaction et d’antagonisme au niveau système qui
favorisent ou handicapent les processus d’innovation. Cet article admet que le jeu de
compétences est le cœur de toute constellation de Triple Hélice; il admet également
que les différentes compétences se manifestent d’une variété de façons, selon la nature
du système considéré et les entreprises associées. Le modèle de jeu de compétences
est conçu en utilisant comme illustration l'émergence de l'industrie des pièces de
rechange humaines à Tampere, en Finlande, pour mettre en évidence une discussion
autre que conceptuelle.
Resumen
Los principales objetivos de este trabajo son: (a) la construcción de un modelo
conceptual genérico para el modelo de la Triple Hélice en base a “conjuntos de
competencias,” y por tanto (b) identificar las competencias genéricas a nivel de
sistema necesarias para el surgimiento de nuevas industrias. Este documento sugiere
una mejora al modelo de la Triple Hélice que consiste en elevar la importancia de
competencias genéricas dentro del análisis institucional. Por tanto, enfatizamos la
necesidad de centrarse en la interacción y el conflicto de competencias transversales
a nivel de sistema que pueden exacerbar o dificultar los procesos de innovación.
Creemos que un conjunto de competencias es el núcleo de cualquier constelación
de la Triple Hélice, pero también creemos que las diferentes competencias se
manifiestan en una variedad de formas, dependiendo de la naturaleza de cada
sistema de innovación y cada industria. Ilustramos el modelo propuesto de conjuntos
de competencias con un análisis del surgimiento de la industria de prótesis humanas
en Tampere, Finlandia.
摘要
本文的主要目的是:(一)基于竞争力集构建三螺旋的一般概念模型;(二)确定在一个
新产业出现过程中所需要的系统级的一般竞争力。本文认为,为了获得分析三螺
旋模型的其他分析工具,我们也需要专注于要求主要机构范畴之间相互作用的一
般竞争力研究。因此,有必要聚焦于相互作用和相互冲突的系统级一般竞争力,不
论它是加强还是防碍创新过程。在此我们相信:一个竞争力集是所有三螺旋星座
的核心;我们也相信:不同的竞争力通过各种不同方式表现出来,取决于具体的系统
和相关产业的性质。通过人类备件产业在芬兰坦佩雷的出现,本文详细说明了竞
争力集模型,以此作为典型案例突出这个相反的一般概念的讨论。
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Aннoтaция
Ocнoвными цeлями дaннoй cтaтьи являютcя: (a) coздaниe oбщeй кoнцeптуaльнoй
мoдeли Tpoйнoй cпиpaли, ocнoвaннoй нa кoмпeтeнцияx, и, oпocpeдoвaннo, (б)
oпpeдeлeниe cooтвeтcтвующиx кoмпeтeнций, учитывaющиx cпeцифику уcлoвий
фopмиpoвaния coвpeмeннoй пpoмышлeннocти. B нacтoящeй paбoтe выдвинутo
пpeдпoлoжeниe, чтo для дocтижeния дoпoлнитeльныx пpeимущecтв в paмкax
мoдeли Tpoйнoй cпиpaли, мы дoлжны пpoaнaлизиpoвaть oбщиe кoмпeтeнции,
нeoбxoдимыe для взaимoдeйcтвия ocнoвныx инcтитутoв дpуг c дpугoм. Taк,
cущecтвуeт пoтpeбнocть в oбщиx умeнияx в oблacти дeлoвыx пepeгoвopoв и
peшeния кoнфликтoв, кoтopыe oпocpeдoвaннo мoгут кaк улучшить, тaк и
зaтopмoзить иннoвaциoнный пpoцecc. Cущecтвуeт мнeниe, чтo нaбop
кoмпeтeнций cocтaвляeт ocнoву Tpoйнoй cпиpaли, a тaкжe чтo paзличныe
кoмпeтeнции пpoявляютcя пo-paзнoму в зaвиcимocти oт уcлoвий, в кoтopыx
cклaдывaeтcя тaкaя cиcтeмa, и oтpacлeй, oтнocящиxcя к нeй. Moдeль нaбopa
кoмпeтeнций paзpaбoтaнa c иcпoльзoвaниeм индуcтpии пoдгoтoвки кaдpoв в
Taмпepe, Финляндия в кaчecтвe пpимepa, cпocoбнoгo пpoиллюcтpиpoвaть
вeдущиecя oбcуждeния.
Resumo
O objetivo desse artigo é: (1) de construir um modelo conceitual genérico para o
modelo de hélice tríplice baseado em conjunto de competências e, portanto, (b) de
identificar as competências genéricas no nível do sistema necessárias na emergência
de uma nova indústria. Esse artigo sugere que para ganhar vantagem analítica
adicional no modelo de Hélice Tríplice, é necessário estuda-lo também se
concentrando nas competências genéricas requeridas para a interação entre as
principais esferas institucionais. Consequentemente, existe uma necessidade de focar
na interação e nos conflitos no nível das competências genéricas que tanto
fortalecem quanto prejudicam o processo de inovação. Acredita-se que um conjunto
de competências definido é o coração de qualquer uma constelação da Hélice
Tríplice, mas também se acredita que competências diferentes são manifestadas de
diversas maneiras dependendo da natureza do sistema específico ou das indústrias
relacionadas. O Modelo de definição do conjunto de competências é elaborado com
base na emergência da indústria de reposição de peças humanas em Tampere,
Finlândia como um caso ilustrativo que põe em evidência a discussão de outra forma
conceitual.
Multilingual abstract
Please see Additional file 1 for translation of the abstract into Arabic.
Introduction
Universities have increasingly been seen as the core instruments of local, regional and
national economic development. This may be a result of the observation that, as many
traditional industries have been hollowing out, and as many local economies have been
losing their leading firms, the university often emerges as one of the few solid and lo-
cally rooted resources to draw upon. It is one of the cores in the dynamic interaction
between ‘the three institutional spheres’, universities, industries and government, foster-
ing entrepreneurship, innovation and economic growth (Etzkowitz and Leydesdorff
1997; Etzkowitz 2008). The core idea of the Triple Helix model revolves around three
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basic premises: (1) universities are playing a central role in innovation side by side with
industries and governments; (2) while earlier innovation policy was to a large extent
designed and implemented by governments, today, it is fairly commonly an outcome of
complex interplay between governments, industries and universities; and contradictor-
ily, the Triple Helix also argues that (3) in addition to taking care of their traditional
functions, the three institutional spheres adopt new roles and also perform the roles of
the other spheres. In this model, actors taking non-traditional roles are seen especially
important and potential sources of innovation (Etzkowitz and Leydesdorff 1997;
Etzkowitz 2008).
Drawing upon their literature review, Cai and Cui (2015) maintain that the Triple
Helix model has not been free of problems. It is criticised for remaining at an abstract
level, lacking solid theoretical basis at a microlevel, not adequately addressing the issues
emerging when actors adopt each other’s roles and lacking the contextual sensitivity
across countries and social settings (Cai and Cui 2015). Additionally, in spite of the fact
that the concept of competence is, at least implicitly, strongly linked to the Triple Helix
literature, it has only recently gained more attention (Ranga and Etzkowitz 2013).
Lester (2007, 1) crystallises the increased need to better understand competences re-
lated to innovation systems by arguing that there are clear differences in the overall
capabilities of nations and regions to adapt to the global economy with equal success.
Some simply seem to be better in taking up new technological and market knowledge
and to apply it effectively. In Triple Helix constellations, competences (in direct and/or
indirect interaction) generate, stimulate and/or frame the overall functioning of a sys-
tem and its transformation (Eliasson 2000). Consequently, as suggested by Ranga and
Etzkowitz, competences also shed light on the ways main actors come together in ‘con-
sensus spaces’, and move to construct ‘innovation spaces’ for realisation of the goals
articulated in a consensus space (see Ranga and Etzkowitz 2013). Our earlier studies in
Finland reveal that while the main actors may trust each other’s integrity and trust-
worthiness, they may have difficulties in trusting mental models and specific
profession-based capabilities of ‘the others’ (Sotarauta et al 2003).
This paper suggests that to gain additional analytical leverage on the Triple Helix
model, and the three spaces in the core of it, we need to study it also by focusing on
generic competences called for in the interaction between the main institutional
spheres. The concept of generic competence refers to those higher order abilities that
are called for to learn, innovate, anticipate and create and/or to generate conditions for
learning and innovation (cf. Brown 1994; Wadhwa and Rao 2000).
As suggested by the ever expanding Triple Helix literature, there is a need to find a
way to link the concept of competence in the debate by reaching beyond the narrow or-
ganisational view. For these reasons, this paper constructs a competence set model aim
being to contribute to the Triple Helix debate. This paper is built on an assumption
that, when enhancing the interaction between the three institutional spheres, there is a
need to understand how a set of competences can be shaped for a more productive col-
laboration. It is exactly to this end, the competence set model is introduced to discuss
the interconnected nature of generic competences required in innovation, business
growth and economic renewal. The second assumption thus is that by the competence
set model, it is possible to understand how competences are spread across the three
institutional spheres and several organisations. The competence set is a configuration
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of competences that in direct and indirect interaction generates new knowledge as well
as its diffusion and valorization (see Eliasson 2000).
The two interrelated research questions we set out to address are what kind of gen-
eric competences are called for in the emergence of a new science-based industry and
how do generic competences interact in a Triple Helix constellation. For this end, the
focus in this paper is on system-level generic competences instead of the competences
of an individual organisation. The concepts of competence and the competence set are
elaborated upon by using the emergence of human spare parts industry in Tampere,
Finland, as an illustrative case to highlight the otherwise conceptual discussion.
Towards a competence set model in the context of Triple Helix
The concept of core competence
In organisation and management studies, the concept of core competence has become
one of the key concepts in the efforts to understand why some firms succeed while
others do not, and, as it is believed in this paper, it has a potential to add analytical
leverage also in studies focusing on Triple Helix constellations. The key rationale in
bringing these fairly disconnected bodies of literature together is that there is much to
be learnt across these broad fields of knowledge. In competence thinking, the basic idea
is that an organisation should comprehend its own core competences and capabilities
in order to utilise the resources available (Pralahad and Hamel 1990). It is also assumed
that competences change more slowly than products and markets, and hence, the iden-
tity of an organisation should not depend on products and markets but on something
more lasting, something that lies at the very core of the organisation’s activities and
success (Tuomi 1999, 82–83). Durand (1998, 306) connects competences directly to an
organisation’s resources and property and to individual and organisational capabilities,
knowledge, processes, routines and culture. Javidan (1998, 62) uses the concept of com-
petence to refer to the combining and coordinating of capabilities cutting across func-
tions. Core competence, drawing upon the theory of Pralahad and Hamel (1990), may
be defined predominantly as a collective learning process across the innovation system.
For its part, generic competence is taken here to be specifically capability and expertise
that is potentially common to several organisations in a Triple Helix constellation but
may also be embedded in a single organisation that has a central position in a system.
Generic competences are thus distributed over many operations either within an organ-
isation or across them, and therefore, from the Triple Helix point of view, it is essential
to approach them from systemic instead of organisational perspectives. For that pur-
pose, a conceptual link between competence thinking and Triple Helix is constructed
by a competence set model.
From competence bloc theory to competence set model
The competence set model is inspired by the competence bloc theory (Eliasson 2000),
but as the competence bloc theory was mainly constructed to better understand and
explain business growth in biotechnology, it needs to be extended with additional com-
petences to provide an analytical tool for broader scrutiny of Triple Helix constella-
tions. The competence of actors and their interaction determines the quality of a
competence set and, as assumed here, also interaction in the context of a Triple Helix.
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Additionally, a set of competences attracts competent investors who contribute posi-
tively to the attractiveness of a Triple Helix constellation (Eliasson 2000). A minimum
critical competence mass and variety are needed before a Triple Helix becomes truly
functional, and, according to Eliasson and Eliasson (1996), the following actors usually
play central roles (modified slightly): (a) competent and active customers and users, (b)
innovators who combine new knowledge and technologies in novel ways, (c) entrepre-
neurs who identify profitable innovations and prepare them for initiation in the market,
(d) competent venture financiers who recognise and finance the entrepreneurs, (e) exit
markets that facilitate ownership change and (f ) industrialists and other established
actors who take successful innovations to industrial-scale production. (Eliasson and
Eliasson 1996).
Eliasson (2000) strongly associates competences with the selection of winning tech-
nologies and corporate winners, and conversely losing technologies and corporations,
and thus, it adds analytical leverage to the Triple Helix relationships that are, according
to Cai (2014), ‘about competition and cooperation for resources, redistribution of
power, and network building’. However, importantly, the Triple Helix model reminds
that the question is not only about selection of ‘winners’ and ‘losers’, or individual com-
panies or narrow industrial sectors, but also more profoundly and broadly about exten-
sive collaboration across institutional spheres for economic growth and renewal. Thus,
the question is about how new knowledge emerges, how it generates variation and how
selection is made, and thus, moving beyond the narrow organisational and sector-based
approaches is fundamental to better support construction of knowledge, consensus and
innovation spaces that play a central role in Triple Helix constellations (Ranga and
Etzkowitz 2013).
As Ranga and Etzkowitz (2013) maintain, the main ingredient in a knowledge-based
economic development is the creation of a knowledge space that, according to them,
‘encompasses the competences of knowledge generation, diffusion and use of the Triple
Helix components’. They define consensus space to refer to a venue that brings
together actors from different organisational backgrounds and perspectives for generat-
ing new strategies and ideas, the ultimate goal being novel discoveries and related inno-
vations. For its part, innovation space refers to new organisational mechanisms that are
geared towards ‘the development of local innovative firms, in parallel with the attrac-
tion of talent and innovative firms from elsewhere, the creation and development of
intellectual and entrepreneurial potential, and competitive advantage for the region and
the country’ (Ranga and Etzkowitz 2013, 247).
Applying Eliasson’s (2000) conceptualisation, the competence set is defined as a con-
figuration of generic competences that in direct and indirect interaction generates new
knowledge as well as its diffusion and valorisation. In other words, competence set is a
group of competences, which belong together or are usually found together. Basically,
the competence set refers to the ability to achieve new forms of competitive advantage
by highlighting the need to continuously renew competences so as to achieve congru-
ence with the changing environment. Moreover, the competence set model may prove
useful in the many efforts to boost innovation spaces, i.e. finding new ways to combine
capital, technology knowledge and business expertise. It therefore follows that a compe-
tence set is a collection of generic competences widely distributed across the three
institutional spheres and hence highlights that competences can be consciously
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reconfigured, redirected, transformed and appropriately shaped, and integrated into
existing competences as well as external resources (cf. Teece et al. 1997). Conversely,
missing and/or poor competences may freeze interactive innovation processes and lock
them in the past.
A sole focus on actors and the relationships between them, typical of innovation
system studies, may even blur the view on how systems actually function and what
drives them; hence, it is important to make a distinction between organisations and
competences. By approaching actors indirectly through competences, it might be pos-
sible to clarify and specify the roles that they play in translating new knowledge into vi-
able products and services. For these reasons, the main rationale in constructing a
competence set model is (a) to specify what kind of competences are called for in a
Triple Helix constellation and (b) to identify the competences that keep a Triple Helix
constellation continuously adapting to changing economic landscapes. The competence
set may thus also be used (c) to serve as a tool in a search for systemic failures as well
as shared interests, problems, opportunities and capabilities, as suggested in the man-
agement literature (Pralahad and Hamel 1990). Consequently, a competence set model
is an analytical tool geared towards identifying how different competences of many
actors could be integrated with one another both horizontally and vertically in such a
way that a constructed set would serve both the entire system and actors embedded
into it. The assumption here is that generic competences need to be identified and ana-
lysed empirically case by case but a thematic framework is needed to guide the search.
The thematic framework was constructed by identifying studies focusing on
innovation system functions, as generic competences are by necessity linked to the
most important functions of any innovation system (see Lundvall et al. 2002; Lundvall
and Lorenz 2006). In the literature on innovation system functions, knowledge devel-
opment and diffusion is, quite self-evidently, acknowledged as a key function (Edquist
2005; Hekkert et al 2007; Hekkert and Negro 2009; Bergek et al 2008; Liu and White
2001). For his part, Eliasson (2000) does not discuss knowledge development as such,
as his theory is dealing more with selection of winning technologies instead of sources
of innovation. Most of the key authors include market formation, framing and cre-
ation of strategic awareness of new technologies and mobilisation in their discussion of
the key innovation system functions (Edquist 2005; Hekkert et al 2007; Hekkert and
Negro 2009; Bergek et al 2008; Jacobsson and Bergek 2004; Rickne 2000). Eliasson
(2000), Hekkert and Negro (2009) and Bergek et al (2008) also incorporate in the set
of system functions entrepreneurial activity. Edquist (2005), Hekkert and Negro
(2009), Bergek et al (2008) and Rickne (2000) remind about the importance of
legitimization, and Eliasson and Eliasson (1996) pay extensive attention to venture
finances. In line with Liu and White (2001), Eliasson and Eliasson (1996) add detec-
tion of end-values in the debate while Edquist (2005), Hekkert and Negro (2009),
Bergek et al 2008, Liu and White (2001) and Rickne (2000) emphasise the importance
of interaction by highlighting networking, exchange of knowledge and bringing
together complementary knowledge.
Following the close reading of the literature on innovation system functions, the
competence set model was constructed to cover seven themes for the empirical work
on the generic competences. Framing, mobilisation and networking were left out from
the framework, as, instead of being system functions, they were identified as generic
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capabilities cutting through all the functions, and as such, they are embedded in the
core competence thinking as well as the Triple Helix model (see e.g. Russel et al. 2015).
Instead, drawing upon Eliasson (2000) and Liu and White (2001), industrial production
or systematic production was included in the analysis, as it appears as important in the
institutionalisation of innovations. The seven themes are the following: (1) knowledge
creation and diffusion, (2) entrepreneurship, (3) finances, (4) legitimisation, (5) market
formation, (6) systematic production and (7) identifying potential end-values. It is im-
portant to keep in mind that the seven functions, labelled here as themes, are not gen-
eric competences as such but they are used in the identification of them. Quite
naturally, each of the themes includes a variety of specific capabilities that construct a
generic competence. In a system-level analysis, the interaction of identified compe-
tences provides further empirical analysis with a point of departure in identifying the
specific capabilities in a context of a specific transformation process of a specific Triple
Helix constellation.
Methodology and case
This paper follows a single case study design to illustrate and highlight how the con-
structed competence set may play out with a case. The study covers the theoretical
middle range in that it aims to understand the emergence of a new industry in its
unique context and construct a conceptual model for adding analytical leverage to the
Triple Helix model.
The emerging regenerative medicine concentration in Tampere and the prospective
Finnish human spare parts industry serves as an example of emerging industry (see
Sotarauta and Mustikkamäki 2015). It does not yet have a direct antecedent in the
economy and thus entails the need to construct new competences and/or transform
existing ones to support the birth and enlargement of an embryonic industry. The
empirical study began in 2014 with the analysis of secondary data, including relevant
journals, related newspaper articles, annual reports and respective policy documents.
This phase identified the state of the art of the human spare parts industry both locally
and globally. Next, 24 people, involved in different capacities in the development of
regenerative medicine in Tampere, Finland, were interviewed in 2014 and early 2015.
Fifteen of the interviewees were employees of BioMediTech (a joint institute of the
University of Tampere and the Tampere University of Technology), and the rest of the
interviewees were from local and regional development agencies, Tampere University
Hospital, Ministry of Employment and the Economy, the Finnish Funding Agency for
Innovation (TEKES) and a local firm. The interview themes were drawn from the com-
petence set model and, in practice, comprised the seven generic competences (see
Fig. 1). The main aim was to construct an understanding of what system-level generic
competences are needed to enhance the emergence of science-based human spare parts
industry and describe the current situation in Tampere. Competences and capacities re-
lated to actual scientific work, knowledge production, are not elaborated, but their im-
portance is, of course, acknowledged, as they form the core in the emergence of any
science-based industry.
The term regenerative medicine was forged in 2000 and is now widely used to
describe biomedical approaches to healing the body by the stimulation of endogenous
cells to repair damaged tissues or the transplantation of cells or engineered tissues to
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replace diseased or injured tissues (Riazi et al. 2009). The basic unit in regenerative
medicine is a stem cell. Stem cells are biological cells found in all multicellular organ-
isms. The potential of stem cells in clinical treatments is based on their multipotent
ability. Stem cells are able to regenerate tissues and organs and act as building blocks
for all tissues in the body (National Institutes of Health 2009). Regenerative medicine
(RM) forms the third discipline in human healthcare alongside medicine and surgery
(Polak et al. 2010), and, from a business point of view, cell therapy is defined as a
fourth pillar in the healthcare industry alongside pharmaceuticals, biopharmaceuticals
and medical devices (Mason and Manzotti 2009). Regenerative medicine has grown
rapidly, and scientific achievements have created hopes for new treatments for severe
incurable diseases, such as diabetes, Parkinson’s disease, cancer and heart diseases. The
promise of regenerative medicine is very exciting, but simultaneously, the cost of prod-
uct development, and most notably clinical trials, for high-end applications is very high
(Mason and Dunnil 2008a, 351).
In Tampere, the scientific research on regenerative medicine is based on close collab-
oration between the University of Tampere and the Tampere University of Technology,
and the first discoveries were based on collaboration between biomaterial engineers,
clinicians, cell biologists, technical experts and animal model experts (Sotarauta and
Mustikkamäki 2015). The two universities institutionalised their collaboration in 2013
by establishing a joint research institute, Institute of Biosciences and Medical Technol-
ogy (BioMediTech), that is a home base for approximately 250 scientists from the two
universities. The unique nature of science and technology created at BioMediTech can
be illustrated by the fact that in 2008, for the first time in the world, a patient’s upper
jaw was replaced with a bone transplant cultivated from the stem cells isolated from
the patient’s own fatty tissue (Sotarauta and Mustikkamäki 2015). The patient had lost
roughly half of his upper jaw because of cancer and traditional medicine was unable to
offer remedial treatment. In the process, the scientists were able to produce new bone
cells by combining stem cells and biomaterials and then grow them into a jawbone of
the correct shape and size (with the aid of a titanium frame) inside the patient’s stom-
ach muscle (Bionext 2010; Sotarauta and Mustikkamäki 2015).
In 2014, the international evaluation panel that carried out an extensive evaluation of
the research activities at the University of Tampere concluded that ‘research conducted
at BioMediTech has an excellent standing nationally and internationally and the
Fig. 1 The seven themes of the competence set model
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number of research projects and output from these projects is commensurate with the
size of the Institute’. The evaluation panel also concluded that the projects are innova-
tive and have clear translational potential in each thematic area of research (Hakala and
Roihuvuo 2014). For its part, the international evaluation panel also asked how it would
be possible ‘to move discoveries from the laboratory or classroom to the clinic and ul-
timately turn these into products, policies or public information that impacts society’
(Hakala and Roihuvuo 2014).
The human spare parts industry discussed through a competence set
Systematic production
Systematic production refers to all those processes and methods that are used to trans-
form science-based discoveries into permanent elements of a healthcare system. In re-
generative medicine, the pressure to detect commercially viable products and services
is increasing steadily but the issue of how to move from research and development to
systematic production has not been fully answered yet (Mason and Manzotti 2009).
One of the ways to translate the potential embedded in the scientific research into the
market is via firms. However, the progress in regenerative medicine, especially in stem
cell-based products, has been fairly modest, as it is fairly commonly seen that there
ought to be clear evidence from phase II clinical trials before even pursuing the com-
mercialisation phase (Parson 2008). The other option is to diffuse potential regenerative
medicine services into medical practice through hospitals.
The prospective human spare parts industry is deeply embedded in scientific re-
search, and those firms that would be interested in operating in the field need to have
access to cutting edge research (Prescott 2011). Conversely, universities are expected to
nurture innovations further into clinical trials before aiming at commercialisation in
contrast to what is usually the case in medical innovation or what is normally expected
before establishing a start-up and obtaining venture finance for it. In the field of regen-
erative medicine, firms need to have access to cutting edge research, as the scientists
introduce new ideas and have the personal level networks needed for generating fund-
ing and establishing a start-up (Murray 2004; Prescott 2011). Therefore, the role of sci-
entists becomes more prominent than is the case in many other fields of medicine as
the markets are underdeveloped and as the demand is only beginning to emerge. Con-
sequently, in a new science-based field like regenerative medicine, the scientific com-
munity needs to be competent not only in science but also in shaping the technology
market, as they may be the only actors who can understand the potential embedded in
the science and technology in question. This again calls for novel competences, and for
these purposes, governments, e.g. in the USA and UK, are establishing regenerative medi-
cine translation centres and funding clinical trials in cell therapy (Mason et al. 2011).
Our interviews clearly revealed that the questions related to systematic production,
either commercially or non-commercially, have been on the agenda in Tampere since
the early days of regenerative medicine-related research (early 2000s) (Sotarauta and
Mustikkamäki 2015). Interviewees revealed how the idea of establishing a ‘Hospital for
Advanced Therapies’ for treating patients suffering from facial bone deficiencies, and
thus exploiting revolutionary new technology, moved to preparatory phase but did
never materialise. Additionally, a special planning group designed a business plan for a
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university-based venture, but it was not executed either. As a member of the manage-
ment team put it: ‘The world [referring to the universities in question and global mar-
kets] was not ready for those ideas yet, nor were we’. Indeed, the core actors have not
found solutions for moving forward beyond clinical experimentations, except licencing
technology to an external party, and it is obvious that the generic competences, in the
system broadly speaking, were not as developed as those in actual science.
The university hospital either has not made any major efforts to establish regen-
erative medicine in its standard repertoire, and it has not proactively constructed
required competences. As a joint municipal authority of 22 municipalities, its mis-
sion is not to serve as an ‘innovation platform for new technology’ but to provide
approximately one million Finns with a timely and equal access to specialised med-
ical care. It, however, conducts clinical research and operates in close collaboration
with the university. The university hospital is not likely to adopt a more strategic
approach in the near future if there will not be significant pressure either from the
society at large (in practice the public healthcare policy) or abundant number of
individual medical doctors. In the future, the hospital’s attitude towards regenera-
tive medicine may be crucial; it is not only becoming legitimised part of the
Finnish healthcare systems but also in moving towards large-scale systematic
production.
In addition, the University of Tampere, the institutional home of regenerative medi-
cine, is the most social science-oriented university in Finland, and hence, its experience
in technology transfer and commercialisation is weak and related competences have
been almost non-existent. For its part, BioMediTech has pushed the university to de-
velop its competences on these fronts. To construct the commercialisation compe-
tences, BioMediTech has utilised the so-called Tutli funding that is a funding
programme of TEKES. It is a specific government policy tool not only to support the
commercialization of potential scientific discoveries but also to construct related com-
petences within universities (Heinonen 2015).
Market formation
What makes the situation especially challenging is that regenerative medicine is a
fairly new and quickly evolving form of science, and human spare parts industry is
in an embryonic state. It is a well-known fact that radical innovations do not pene-
trate economies without emergence of a new market or significant changes in an
existing one, and therefore, understanding the dynamics of market formation is
seen here as one of the generic competences. Even though understanding of mar-
ket formation is considered here as one of the generic competences in a compe-
tence set, its driving forces are more often than not considered as exogenously
defined, and typically, it is seen to follow linear change patterns. Market formation
is often described as proceeding from a nursing phase to a bridging phase to a
mass market (Jacobsson and Bergek 2004), and each of these phases is associated
with specific barriers and challenges (Dewald and Truffer 2011, 287). An elaborate
understanding of market formation processes needs to take into account the co-
evolution of the technological, institutional, political and user-related aspects of
innovation and related markets (Dewald and Truffer 2011, 286). Even though it is
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virtually impossible to influence the market formation from a single location, it is
vitally important to construct competences to monitor and understand market for-
mation dynamics for seizing the opportunities when they emerge. In locations like
Silicon Valley, with abundant influential actors from different areas of the market,
it is possible to witness markets evolving, but in more peripheral locations like
Tampere, there is a need for active competence building for entering emerging
markets. In Tampere, it is well understood that there is a need to reach inter-
national markets and funding sources, as the country is small and opportunities
thus limited. It is also understood that there is a need to strengthen the collabor-
ation with the Finnish hospitals to gain first-user references close to home and
make sure that the benefits of the science in question are available in the country
that has funded the research.
In BioMediTech Tampere, strategic awareness about emerging markets is fairly
good at a general level but shared generic competences to exploit emerging oppor-
tunities are not well developed. Additionally, the core actors in Tampere are not
familiar with the international markets, specific to those products and services Bio-
MediTech is specialising in, and there is no systematic monitoring of them either.
BioMediTech has received public funding from national and local sources to
strengthen its capacity to operate in the global markets but the specific compe-
tences to monitor and assess the emergent human spare parts industry are not sys-
tematically developed, and the interviews indicate that their relevance as a part of
the system are not fully understood. BioMediTech Tampere has been fairly inward
looking and has not aimed at tapping into expertise of public and/or semi-public
development agencies that has been established to be of support to these kinds of
commercialisation efforts. Instead, there are signs of widening gap between BioMe-
diTech, development agencies and also firms. This is due to many national factors
(see below), the most important local issue being that the earlier fairly well-
established sharing of joint and individual competences (see Sotarauta and
Mustikkamäki 2015) has been fading away as the universities have been struggling
with the many internal issues related to founding a joint institute between two
individual universities. However, BioMediTech and local and regional development
agencies are slowly awakening to realise the consequences of unbalanced local
system, and new competences are being built but they are still in their early phases
of development.
At all events, the human spare parts industry has only begun to emerge; the
market formation has barely begun. It is an emerging industry without an estab-
lished position yet. According to Alliance for Regenerative Medicine (ARM 2014),
there are approximately 700 companies globally in the field of regenerative medi-
cine (out of which 247 companies are dedicated to cell therapies). ARM divides
the emerging market to four sub-groups: therapeutics and devices (56 %), tools
(19 %), tissue banks (13 %) and services (12 %). According to Grand View Research
(2013), in 2013, the estimated size of the regenerative medicine market size was
$30.16 billion from which the stem cell technology market was $12.8 billion.
Depending on what industries are included in regenerative medicine, market size
estimations vary greatly but as the clinical trials proceed, also, the science push
increases.
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Entrepreneurship and venture finances
As entrepreneurs take advantage of new business opportunities generated by new
knowledge, and as they turn the potential of new knowledge, networks and markets
into new business opportunities (Hekkert et al. 2007), their generic competences re-
lated to market understanding are of importance in moving towards commercialisation
and potentially also making regenerative medicine an elemental part of the healthcare
system. Additionally, entrepreneurs possess generic competences that enhance gener-
ation of diversity and diffusion of new knowledge (Drucker 2014; see for university-run
enterprises, Zhou 2014). Entrepreneurial activity is usually considered one of the core
activities in selecting viable alternatives from emerging ideas and knowledge (Hekkert
et al. 2007). Quite naturally, in contrast to a scientist, whose main motivation is to cre-
ate new knowledge and thus also novel opportunities, the entrepreneur’s motivation
revolves around the practical actualisation of these (Drucker 2014).
In BioMediTech, as explained in the previous sections, the competences related to
science and technologies have developed favourably but business formation has yet to
emerge. There have been over 10 spin-off firms as well as around 100 patents from Bio-
MediTech and its predecessors, but the firms have not grown substantially. In Tam-
pere, there are several biomaterial firms but, at least so far, no such entrepreneurs have
surfaced, which would exploit the science and technology created in BioMediTech.
Furthermore, there are no discussions between existing firms in Finland and BioMedi-
Tech or strategic efforts to create a nourishing local ecosystem for start-ups to emerge
and grow. The current commercialisation strategy of BioMediTech focuses more on
detecting major international dedicated actors to collaborate with than aiming at creat-
ing a local start-up ecosystem. All in all, our interviews clearly indicated that the gen-
eral atmosphere towards the idea of having start-ups linked to BioMediTech is
favourable, and there are several projects aimed at developing proofs of concept and
raising funds for the next stages, but, as the competences related to boosting start-up
community are still poorly developed, the international incumbents are seen as a
favourable route forward. At BioMediTech, several explicit support measures to
strengthen the entrepreneurial competences have been launched. These include recruit-
ing additional staff with complementing capabilities in issues related to commercialisa-
tion, patenting and licencing; training scientists for commercialisation and seeking help
to construct local competences from the USA and Belgium. Indeed, our interviews in-
dicated clearly that these have been necessary but not sufficient measures if other com-
petences in the system do not develop favourably. The efforts are more based on
strengthening competences in a single organisation, instead that of an entire system,
and therefore, the measures do not meet the scope of challenges.
Public funding has been extensively received to support the emergence of regenera-
tive medicine but private venture finance has not found its way to Tampere, and hence,
there is a need to find a proper balance between finding dedicated incumbents to col-
laborate with and supporting establishment of venture finance-backed start-ups to
showcase the local scientific potential and, of course, to grow by themselves if possible.
A well-functioning Triple Helix constellation requires competent venture financiers
who recognise and finance the entrepreneurs, and hence, for their part, play an import-
ant role in the selection process. As previously shown, the catalytic role of venture fi-
nanciers is often crucial in the emergence of new industries (Florida and Kenney 1988;
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von Burg and Kenney 2009). The challenge for new ventures is to ‘carve out a new mar-
ket, raise capital from sceptical sources, recruit untrained employees, and cope with
other difficulties stemming from their nascent status’ (Aldrich and Fiol 1994, 645).
Moreover, as Pisano (2006) argues, biotechnology is a challenging sector for three rea-
sons: (a) the uncertainty of the outcomes of the science and technology, (b) the hetero-
geneous and complex nature of the science, and (c) the need for long cumulative
learning. All this calls for patient and future-oriented funding. These observations de-
scribe the situation BioMediTech is facing very well.
Additionally, the difficulty is that there are no Finnish venture capitalists that would
invest in regenerative medicine, and as a whole, Finnish venture capital is a scarce re-
source (Sorvisto and Sotarauta 2016). The competences to fund the commercialization
of regenerative medicine are poorly established in Finland. For these reasons, to raise
venture capital BioMediTech needs to seek it from abroad but the abilities to sell the
idea to a foreign venture capitalist have yet to emerge, and there are no real connec-
tions to potential venture capital sources, i.e. ‘independently managed dedicated pools
of capital that focus on equity or equity-linked investments in privately held, high
growth companies’ (Gompers and Lerner 1999, 349).
The emerging human spare parts industry in Tampere is not alone in its lack of
entrepreneurial activity and difficulties in acquiring funding for commercialisation (see
Hellman et al. 2011; Johnson et al 2011; Martin et al 2006), as it is the anatomy of the
industry in itself (Pisano 2006). All this may be due to the fact that, in spite of huge
promises, the market for the human spare parts industry has yet to emerge, and there-
fore, the competent companies and entrepreneurs have not seen the business oppor-
tunity yet in a broad sense. As suggested, a standard venture capital model is not
working in cases where a large amount of money (e.g. $100 million) and time (e.g. at
least 10 years) are needed to finalise a product (Reynolds et al. 2013). In regenerative
medicine, technological risk and burn rates are high, and a combination of high risk
and long time-span is not a lucrative opportunity for a financier. For these reasons,
according to Mason (2007), since the early enthusiasm of the 1990s, the funding in re-
generative medicine has switched from venture capital and pharmaceutical firms to
public finance, philanthropists and military sources. Regenerative medicine is a fairly
typical case of an emerging science-based field that draws heavily on public funding,
and private venture financiers become interested in the potential of its innovations only
in the later phases of clinical trials (Parson 2008).
Mason (2007) states that three factors make it possible for a new venture to succeed:
expert business management, simple but superior products and scalability of manufac-
ture (Parson 2008). Consequently, for a venture capitalist to be convinced about a mar-
ket potential of a novel product or service: (a) medical needs must be clearly identified,
(b) savvy management team needs to be in place and (c) intellectual property needs to
be protected (Parson 2008). Prescott (2011) also highlights the importance of third
party endorsement for the product and an effective sales and marketing strategy. In
Tampere, there are not savvy management teams attached to the local system that
would possess the competences needed in moving forward, and neither there are prod-
ucts nor services packaged for international markets. In consequence, the generic com-
petences needed in exploiting the opportunities in the emergence of new industry are
still to be constructed.
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Legitimisation
Simultaneously, with the high hopes embedded in regenerative medicine, the emerging
human spare parts industry faces both complex ethical and legislative issues and diffi-
culties typical to new emerging industry, and hence, its emergence cannot be fully
grasped without full appreciation of the issues related to legitimisation.
As innovation needs to become part of an incumbent regime, a new emerging indus-
try needs to establish itself as a part of several systems (Hekkert and Negro 2009;
Aldrich and Fiol 1994). To accomplish this, various actors need to innovate against the
logic of those systems that are supposed to support them, and thus, generic compe-
tences related to legitimisation may be of utmost importance. It is worth reminding
that the question is not about legitimating human spare parts industry in one specific
system but several systems and hence broadly in the society. In the case under scrutiny,
these are not only healthcare, science and innovation systems but also local/regional
economic development systems.
Lack of legitimacy may be among the main obstacles for new ventures operating in
emerging industries and/or markets, as new products, services and processes need to
overthrow the existing regime. That, of course, frequently causes uncertainty and social
anxiety. Consequently, reduction of social uncertainty and dealing with resistance to
change are among the generic competences needed in an innovation system. These are
here combined under the concept of legitimisation. Legitimisation refers to the socio-
political process of legitimacy formation through actions by various organisations and
individuals. Central features are the formation of expectations and visions as well as
regulative alignment, including issues such as market regulations, tax policies and di-
rections of science and innovation policy (Bergek et al. 2008). Legitimisation is about
acquiring social acceptance of innovation, and it is a process that makes an innovation
conform to the prevailing institutions (norms, values, habits and regulations) and/or to
a process that targets the change of institutions for something new to emerge (Bergek
et al 2008). Legitimisation is one of the most central selection mechanisms in any
Triple Helix setting.
Earning legitimacy is a demanding process, as a society is unfamiliar with the indus-
try and new innovations related to it. The human spare parts industry is not well
defined yet, and there are only few or no standards and/or products and services
against which society can judge the industry as appropriate. Of course, conversely, am-
biguous or non-existing standards and services also present a great opportunity for a
new venture in an emerging industry, as they may take a lead in defining the industry,
determining the standards for it and establishing a dominant design for an entire field,
and thus create legitimacy for the industry. In practice, it is rare that one single actor
might be in a position to push for legitimacy alone, and more often than not it calls for
actions from public, private and academic actors. There are multiple ways to legitimate
a new industry. At the organisational level, ventures must build trust with customers,
firms in related industries and industry members. They also need to develop a know-
ledge base by clearly defining issues (e.g. the level of abstraction, use of existing know-
ledge, internal consistency) (Aldrich and Fiol 1994),
Mason and Dunnil (2008b) point out the importance of widely accepted technical
standards because the lack of early agreement on standards might be damaging to the
human spare parts industry. Currently, in developed countries, it is, of course, almost
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impossible to bring new therapies or medical devices into clinical use without any regu-
latory approval. Regulatory bodies, though, are not always up to date about biomedical
scientific understanding and possibilities of technology, and thus, there are examples of
evolutionary trajectories where regulation co-evolves with the innovation process and
the market (Metcalfe et al. 2005). Statutes concerning clinical medical research in gen-
eral cover much of the stem cell-based research, and only a few countries have adopted
legislation devoted to stem cell research per se. In Finland, the ethical atmosphere and le-
gislation have mostly been permissive (Stem cell research in the Nordic countries 2007).
In Tampere, realised experimental treatments have been regulated under Hospital Ex-
emption for Advanced Therapy Medicinal Products (ATMP). Even after several suc-
cessful experimental treatments, and established expertise to cultivate bone tissue from
stem cells, regulators do not fully know what the regulatory details are for these kinds
of new products and treatments in Finland. There actually is an on-going dialogue be-
tween the regulators and representatives of BioMediTech to find out what is actually
required and how to carry it out, and thus, the Tampere case confirms the earlier ob-
servations that regulation co-evolves with the innovation process and the market in the
emerging industries (Metcalfe et al. 2005). In Finland, regenerative medicine is well
legitimised in the science system including science and innovation funding but it is not
as well legitimised in the healthcare system, as the treatments are mainly case-by-case
experiments rather than established parts of the standard repertoire of the hospitals
and the entire system. According to our interviews, in the hospital, the individual med-
ical doctors comprise the core in the efforts to exploit the discoveries of regenerative
medicine, and thus to legitimise it in their own specialisation areas, and so far, there
has only been few champions for these efforts. Therefore, the limitation of a physician’s
responsibility regarding harm done to a patient during a treatment may have a major
impact on clinical practice as well as new product and service development. If physi-
cians alone carry the responsibility, the will to take risks at individual level is small
compared to a situation where the government, hospital or a system as a whole carries
part of the liability. In Finland, physicians are fairly well positioned to experiment with
new technologies as the responsibility is shared in the system.
End-values
Liu and White (2001) suggest that, in the spirit of demand-led innovation, end-use-
generated innovation needs to be better acknowledged than earlier recommended in
the innovation system literature. However, in the early stages of regenerative medicine-
related products and services, it is fairly hard to see user- or demand-led innovation
emerging. The entire field is pushed forward by new developments in science, and the
‘customer imagination’ is not developed enough to demand new kinds of services.
However, as the field is characterised by high hopes and global hype, there are a variety
of expectations. Public policymakers and funding bodies are looking forward to
increased employment and globally leading positions in a new trending field; our inter-
views revealed that this is the case in Tampere too. Scientists, for their part, aim to
push the scientific frontier forward but also seek citations and fame. And of course, ul-
timately, there are incurable or difficult to cure diseases and thus plenty of patients
who might benefit from scientific breakthroughs in regenerative medicine providing
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them with new hope. In all cases, potential and actual beneficiaries of innovations in re-
generative medicine consist of heterogeneous sets of actors that all have their own
hopes and fears. Expectations are not as clear as we might assume; any Triple Helix is
a nexus of many expectations and desires, and hence, consensus spaces are of import-
ance, but not easily constructed and maintained. Therefore, it is important to scrutinise
what the potential end-results might be by focusing on not only the end-use of specific
innovations, or demand-led innovation, but also the end-values various actors expect to
get out of it. It is important to note that ‘a firm’, ‘product’ or ‘service’ is not an end-
value, as is often seen, but the value generated for the society, economy and individuals
at large.
In Tampere, there have been only limited discussions, not to mention public debates,
on the end-values, and it may be that the lack of public debates are among the reasons
why legitimisation processes are still uneven depending on the sub-system, and why
market offerings have been slow to emerge, and why the Tampere University Hospital
has not adopted a more strategic attitude towards it. In Tampere, there are no efforts
to boost public discussion on the public and/or private end-values of the money
invested in regenerative medicine either, and it seems clear that there is no widely
shared awareness of the importance of public debates in the emergence of a new indus-
try and thus no competences to set these in motion. Perhaps, the human spare parts
industry has not begun to emerge in Finland, as it is globally underdeveloped, funding
is scarce but also because there is no public debate concerning the end-values or poten-
tial risks involved in regenerative medicine and human spare parts industry.
The core actors have not understood the value of generating a public discussion on
the future prospects of regenerative medicine and human spare parts industry more
broadly. As the end-values are only vaguely debated outside the scientific and some
policy circles, it also is difficult to begin a systematic construction of such competences
that are needed in taking major steps forward. In addition, there are no ‘innovation
evangelists’ who would work for increased awareness of the emerging industry and
build a critical mass and competent management teams of support for it. An evangelist
is a special role in the system with established competences in promoting the use of a
particular technology through talks, bonding with gatekeepers, writing articles for pro-
fessional as well as general media, blogging, boosting user demonstrations, presenting
recorded demonstrations or the creation of sample projects (Beatty and Gordon 1991;
Lucas-Conwell 2006). Innovation evangelists are playing an important role in the con-
struction of collective beliefs that again are central in a design of new strategies (Sotar-
auta 2016) and construction of related competences.
Conclusions
This paper suggests that to truly understand the dynamics of the Triple Helix model
and how new discoveries are commercialised and diffused into the society, there is a
need to study also interacting generic competences that either enhance or hamper col-
laboration in Triple Helix constellations. Moreover, it is believed that construction of
well-functioning innovation and knowledge spaces, and related consensus space, calls
for novel ways to analyse and develop interrelated but differing competences from
Triple Helix instead of organisational perspectives (see also Ranga and Etzkowitz 2013).
For these purposes, a set of generic competences was introduced and discussed, and it
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was also shown how they play together, or not, in a specific case. The dominant generic
competences are related to the generation of new knowledge and the selection of win-
ning knowledge, products and/or services and retention of them in the economy, but,
as was shown, several other generic competences are called for in the system to make a
lasting impact on the society, to institutionalise the new discoveries. As the case study
reported in this paper shows, it may be difficult to move beyond scientific excellence in
an emerging field, in which not all the generic competences have developed yet to sup-
port each other. Any Triple Helix constellation is by definition a complex ensemble of
actors, and as the Tampere case also reveals, in the course of events, it may be fairly
difficult to see how the lack of competences related to making sense of emerging mar-
kets, debating potential end-values and legitimisation may end up hampering the func-
tionality of consensus and innovation spaces, and thus also seemingly straightforward
commercialization efforts.
The main obstacles in a case under scrutiny are related to insufficient funding, diffi-
culties in the technology transfer processes, poor understanding of emerging markets
and acquisition of capabilities needed in the form of competent management teams.
Many of these issues are beyond what can be expected from universities only, and quite
naturally, the emergence of the human spare parts industry is dependent on many
competences of all three institutional spheres of the Triple Helix model. It might be
possible to argue, for example, that the local university hospital, owned by the local
government, ought to integrate new treatments into its standard repertoire, but, in
practice, the mix of potential end-values are poorly identified and not properly debated,
and thus, it is difficult for the hospital to take necessary measures or even understand
what is at stake. And here, the competences of social scientists and/or local politicians
might prove invaluable. Moreover, it would be easy to suggest that the universities
ought to strengthen their competences related to entrepreneurship, market formation,
technology transfer and commercialization, but as important, it is to ask where comple-
mentary competences could be found from and how they could be tapped into and in-
tegrated into the local Triple Helix constellation. So far, they have been found in the
USA and Belgium. In addition, there is a medical technology-specialised local develop-
ment agency that played a central role in the early phases of regenerative medicine (see
Sotarauta and Mustikkamäki 2015), but as the role of intermediaries has been ques-
tioned in the Finnish innovation system, it has been disintegrating from more recent
developments. Interestingly, from a national innovation system point of view, this may be a
well-argued position but, from a competence set point of view, well established, much
needed and valuable local competences have been side-tracked more or less unintentionally.
The conclusion, and proposition for future on studies on triple helices, is that a balanced
competence set influences positively the functionality of Triple Helix constellations, and
more specifically knowledge, consensus and innovation spaces in the core of them, and
provides all three institutional spheres with a tool to customise their interaction. It is im-
portant to note that the generic competences and a competence set based on them may be
universally needed but their manifestations vary across countries and regions; different ac-
tors may introduce different generic competences depending on the past path, the system
and the expertise of individual actors. Thus, the concept of competence set provides a tool
to discuss the roles of various actors in a Triple Helix, and the competences they bring into
play, and especially to detect poorly developed or non-existing competences.
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